NEW YORK, Aug. 4 /PRNewswire-FirstCall/ — Delcath
Systems, Inc. (Nasdaq: DCTH) announced today that management will
present at the 30th Annual Canaccord Global Growth Conference in
Boston, MA on Thursday, August 12, 2010 at 8:30 a.m. ET. Mr. Eamonn Hobbs, Chief Executive Officer, and
Mr. David McDonald, Chief Financial
Officer, will provide an overview of the Company’s business
strategy and recent corporate developments.
Attendance at this conference is by invitation only. Delcath
will offer a live audio webcast of its presentation, which may be
accessed on the Investor Relations section of the Company’s website
at www.delcath.com. An
archived replay of the presentation will be available for 30 days,
also at www.delcath.com.
About Delcath Systems
Delcath Systems, Inc. is a development stage, specialty
pharmaceutical and medical device company focused on oncology.
Delcath’s proprietary system for chemosaturation is designed to
administer high dose chemotherapy and other therapeutic agents to
diseased organs or regions of the body, while controlling the